Rhumbline Advisers »

Halozyme Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2013-03-31 $565k 98k 5.77
2012-12-31 $722k 108k 6.71
2012-09-30 $824k 109k 7.56
2012-06-30 $872k 99k 8.86
2012-03-31 $1.1M 90k 12.76
2011-12-31 $834k 88k 9.51
2011-09-30 $721k 117k 6.14
2011-06-30 $806k 117k 6.91
2011-03-31 $780k 116k 6.71
2010-12-31 $865k 109k 7.92
2010-09-30 $783k 102k 7.71
2010-06-30 $883k 125k 7.04
2010-03-31 $846k 106k 7.99
2009-12-31 $533k 91k 5.87
2009-09-30 $646k 91k 7.11
2009-06-30 $625k 90k 6.97
2009-03-31 $452k 83k 5.45
2008-12-31 $401k 72k 5.60
2008-09-30 $419k 57k 7.34
2008-06-30 $307k 57k 5.38
2008-03-31 $379k 60k 6.36
2007-12-31 $426k 60k 7.11
2007-09-30 $489k 56k 8.68
2007-06-30 $520k 56k 9.23